4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-006578
SVP and General Counsel sold 2,813 shares at an average $56.51 ($158,959)
- SVP and General Counsel acquired 2,813 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taylor Stacy L SVP and General Counsel | 2021-01-29 | Option exercise | +1,042 | $7.80 | $8,128 | 2,342 | D: show line 1 in the form |
| Taylor Stacy L SVP and General Counsel | 2021-01-29 | Option exercise | +1,771 | $6.55 | $11,600 | 4,113 | D: show line 2 in the form |
| Taylor Stacy L SVP and General Counsel | 2021-01-29 | Sale | −1,095 | $55.71 | $61,002 | 3,018 | D: show line 3 in the form |
| Taylor Stacy L SVP and General Counsel | 2021-01-29 | Sale | −1,090 | $56.59 | $61,683 | 1,928 | D: show line 4 in the form |
| Taylor Stacy L SVP and General Counsel | 2021-01-29 | Sale | −628 | $57.76 | $36,273 | 1,300 | D: show line 5 in the form |
| Open-market sales · 2,813 sh · avg $56.51 · $158,959 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Taylor Stacy L SVP and General Counsel | 2021-01-29 | Option exercise · Stock Option (Right to Buy) | −1,042 | 28,125 | D: show line 6 in the form | |||||
| Taylor Stacy L SVP and General Counsel | 2021-01-29 | Option exercise · Stock Option (Right to Buy) | −1,771 | 24,792 | D: show line 7 in the form |
Loading xslF345X03/doc4.xml…